526 related articles for article (PubMed ID: 25360765)
1. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.
Iturrieta-González IA; Padovan AC; Bizerra FC; Hahn RC; Colombo AL
PLoS One; 2014; 9(10):e109553. PubMed ID: 25360765
[TBL] [Abstract][Full Text] [Related]
2. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL
Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116
[TBL] [Abstract][Full Text] [Related]
3. Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients.
Montoya AM; Elizondo-Zertuche M; Treviño-Rangel RJ; Becerril-García M; González GM
Rev Iberoam Micol; 2018; 35(1):22-26. PubMed ID: 29287630
[TBL] [Abstract][Full Text] [Related]
4. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
5. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
6. Molecular Identification, Genotyping, Phenotyping, and Antifungal Susceptibilities of Medically Important Trichosporon, Apiotrichum, and Cutaneotrichosporon Species.
do Espírito Santo EPT; Monteiro RC; da Costa ARF; Marques-da-Silva SH
Mycopathologia; 2020 Apr; 185(2):307-317. PubMed ID: 31776790
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
Rastogi V; Honnavar P; Rudramurthy SM; Pamidi U; Ghosh A; Chakrabarti A
Mycoses; 2016 Aug; 59(8):528-34. PubMed ID: 27144725
[TBL] [Abstract][Full Text] [Related]
8. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance.
Di Bonaventura G; Pompilio A; Picciani C; Iezzi M; D'Antonio D; Piccolomini R
Antimicrob Agents Chemother; 2006 Oct; 50(10):3269-76. PubMed ID: 17005804
[TBL] [Abstract][Full Text] [Related]
9. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina.
Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G; Bosco-Borgeat ME
Med Mycol; 2014 May; 52(4):356-66. PubMed ID: 24682113
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility patterns and molecular identification of Trichosporon species.
Rodriguez-Tudela JL; Diaz-Guerra TM; Mellado E; Cano V; Tapia C; Perkins A; Gomez-Lopez A; Rodero L; Cuenca-Estrella M
Antimicrob Agents Chemother; 2005 Oct; 49(10):4026-34. PubMed ID: 16189076
[TBL] [Abstract][Full Text] [Related]
11. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Araujo Ribeiro M; Alastruey-Izquierdo A; Gomez-Lopez A; Rodriguez-Tudela JL; Cuenca-Estrella M
Rev Iberoam Micol; 2008 Dec; 25(4):221-5. PubMed ID: 19071890
[TBL] [Abstract][Full Text] [Related]
12. Invasive Infections Due to
Guo LN; Yu SY; Hsueh PR; Al-Hatmi AMS; Meis JF; Hagen F; Xiao M; Wang H; Barresi C; Zhou ML; de Hoog GS; Xu YC
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463892
[TBL] [Abstract][Full Text] [Related]
13. Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients.
Almeida AA; Crispim Bdo A; Grisolia AB; Svidzinski TI; Ortolani LG; Oliveira KM
Rev Argent Microbiol; 2016; 48(1):62-6. PubMed ID: 26916812
[TBL] [Abstract][Full Text] [Related]
14. Aspects related to biofilm production and antifungal susceptibility of clinically relevant yeasts of the genus Trichosporon.
Lara BR; de Camargo BB; Paula CR; Monari GPM; Garces HG; Arnoni MV; Silveira M; Gimenes VMF; Leite Junior DP; Bonfietti LX; Oliveira L; Melhem MSC; Auler M; Ramos RTB; Dias ALT; Silva NC; Moreira D; Richini-Pereira VB; Anversa L; Ruiz LDS
Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36807459
[TBL] [Abstract][Full Text] [Related]
15. Farnesol inhibits planktonic cells and antifungal-tolerant biofilms of Trichosporon asahii and Trichosporon inkin.
Cordeiro RA; Pereira LMG; de Sousa JK; Serpa R; Andrade ARC; Portela FVM; Evangelista AJJ; Sales JA; Aguiar ALR; Mendes PBL; Brilhante RSN; Sidrim JJDC; Castelo-Branco DSCM; Rocha MFG
Med Mycol; 2019 Nov; 57(8):1038-1045. PubMed ID: 30649480
[TBL] [Abstract][Full Text] [Related]
16. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
Tsai MS; Yang YL; Wang AH; Wang LS; Lu DC; Liou CH; Hsieh LY; Wu CJ; Cheng MF; Shi ZY; Lo HJ
Mycopathologia; 2012 Aug; 174(2):121-30. PubMed ID: 22318636
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates.
Cong L; Liao Y; Yang S; Yang R
PLoS One; 2016; 11(12):e0167903. PubMed ID: 27930704
[TBL] [Abstract][Full Text] [Related]
18. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
Ruan SY; Chien JY; Hsueh PR
Clin Infect Dis; 2009 Jul; 49(1):e11-7. PubMed ID: 19489711
[TBL] [Abstract][Full Text] [Related]
19. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing.
Chagas-Neto TC; Chaves GM; Melo AS; Colombo AL
J Clin Microbiol; 2009 Apr; 47(4):1074-81. PubMed ID: 19225102
[TBL] [Abstract][Full Text] [Related]
20. In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii.
Li H; Lu Q; Wan Z; Zhang J
Int J Antimicrob Agents; 2010 Jun; 35(6):550-2. PubMed ID: 20202797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]